Literature DB >> 15280852

Hydroxyurea-associated squamous dysplasia.

Carla Sanchez-Palacios1, Joan Guitart.   

Abstract

We report 2 cases of squamous dysplasia associated with long-term hydroxyurea therapy. The association between hydroxyurea and multiple aggressive squamous cell carcinomas, Bowen's disease, and multiple actinic keratoses in sun-exposed areas after a variable latency period has been increasingly reported. On reviewing the literature, 17 cases were identified and are reviewed, with emphasis on possible pathogenetic mechanisms of carcinogenicity. Squamous dysplasia, a precursor state to a more aggressive condition of multiple squamous cell carcinomas in photoexposed areas, should be added to the well-known cutaneous toxicities of hydroxyurea therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15280852     DOI: 10.1016/j.jaad.2003.11.059

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  7 in total

Review 1.  Hyperkeratotic Skin Adverse Events Induced by Anticancer Treatments: A Comprehensive Review.

Authors:  Maria Vastarella; Gabriella Fabbrocini; Vincent Sibaud
Journal:  Drug Saf       Date:  2020-05       Impact factor: 5.606

2.  Rapidly Growing and Aggressive Cutaneous Squamous Cell Carcinomas in a Patient Treated with Ruxolitinib.

Authors:  Álvaro March-Rodriguez; Beatriz Bellosillo; Alberto Álvarez-Larrán; Carles Besses; Ramon M Pujol; Agustí Toll
Journal:  Ann Dermatol       Date:  2019-02-28       Impact factor: 1.444

3.  A multidisciplinary team approach to hydroxyurea-associated chronic wound with squamous cell carcinoma.

Authors:  Tamar Stone; Alexandra Berger; Sheila Blumberg; Daniel O'Neill; Frank Ross; Alexander McMeeking; Weiliam Chen; Irena Pastar
Journal:  Int Wound J       Date:  2011-11-17       Impact factor: 3.315

4.  [Cutaneous side effects of hydroxyurea treatment for polycythemia vera].

Authors:  N-P Hoff; S Akanay-Diesel; U Pippirs; K-W Schulte; S Hanneken
Journal:  Hautarzt       Date:  2009-10       Impact factor: 0.751

5.  Sustained Regression of Hydroxycarbamide Induced Actinic Keratoses after Switching to Anagrelide.

Authors:  Georgios Gaitanis; Dora Gougopoulou; Eleni Kapsali; Ioannis D Bassukas
Journal:  Case Rep Dermatol Med       Date:  2018-03-27

Review 6.  Clinical utility of ingenol mebutate in the management of actinic keratosis: perspectives from clinical practice.

Authors:  Nevena Skroza; Nicoletta Bernardini; Ilaria Proietti; Concetta Potenza
Journal:  Ther Clin Risk Manag       Date:  2018-10-04       Impact factor: 2.423

Review 7.  Transformation from polycythemia vera to acute promyelocytic leukemia: Case report and literature review.

Authors:  Wen-Wen Li; Xiu-Fang Sui; Shuang Fan; Hong Xu; Cheng-Lei Wang; Fei-Ying Wang; Xiao-Dong Mo
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.